Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe banner about NIH’s terminology transition and related updates is no longer displayed. The page continues to show a 403 Forbidden error.SummaryDifference1%

- Check15 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains inaccessible on the page.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the study page remains an error page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study page continues to display a 403 Forbidden error instead of study information.SummaryDifference0.2%

Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.